Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Friday, 29th October 2021 to approve and take on record unaudited consolidated & standalone Financial Results of the Company for the second quarter and half year ended 30th September 2021, consider declaration of interim dividend, if any, for the financial year ending 31st March 2022, and fixation of Wednesday, 10th November 2021 as the Record Date for the payment of interim dividend, if declared.
The above information is a part of company’s filings submitted to BSE.
